Wegovy 7.2mg, the newly approved higher dose, produced an average of 20.7% weight loss in the same trial, with 33.2% of participants achieving 25% or more weight loss, a result previously only associated with bariatric surgery or Mounjaro 15mg This means that the gap between the two medications in terms of results has narrowed considerably with the introduction of Wegovy 7.2mg
During the GLP-1 shortage era, Empower became one of the most widely used backend pharmacies across the telehealth weight loss industry, supplying compounded semaglutide and tirzepatide to a large network of clinics and platforms nationwide
Patients often report similar appetite suppression, weight loss trajectories, and tolerability profiles between the two, making the cost savings a significant advantage for long-term adherence
Su textura es ligera y se absorbe rpidamente, lo cual facilita su uso diario
Selenium Supports cellular protection and works alongside glutathione enzymes to reduce oxidative damage